Recently by Simone M. Peek
Anti-Corruption
Medical Device Companies: Testing FCPA Compliance Program Effectiveness In Emerging Markets
Medical device companies that do business in emerging markets face the prospect of great reward as well as great risk. Increasingly, one of the major risks is exposure to the U.S. Foreign Corrupt Practices Act ("FCPA") and similar international anti-bribery laws and regulations. A key...
Read More